Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.
Johnson & Johnson has been hit with a class action for allegedly pushing ineffective cold and flu medications containing phenylephrine onto customers for decades.
A judge has signed off on a bill that brings the total settlement administration costs in a class action against Johnson & Johnson unit De Puy to over $13 million, amid a push by some judges to open the settlement administration gig up to competition.
As Johnson & Johnson loses its second attempt to use bankruptcy protection to resolve tens of thousands of US cases over its talcum powder products, a law firm has launched a class action investigation on behalf of Australian women who regularly used the powder and were later diagnosed with cancer.
A former top judge appointed to decide the first-ever contest to administer a class action settlement has set out his criteria for making the choice, and has warned that giving the firm running a case a monopoly right to dole out the proceeds could lead to higher costs for group members and poorer settlement outcomes.
Shine Lawyers’ bid to recoup “exorbitant” interest on a loan it took out to run pelvic mesh class actions against Johnson & Johnson has raised new ethical dilemmas beyond the usual “sweaty palms and huge vexation” in most group proceedings, a judge has said.
Shine Lawyers can deduct 50 per cent of its fees and all of its costs from a $300 million settlement in pelvic mesh class actions against Johnson & Johnson while a judge mulls whether the law firm’s total bill is fair and reasonable.
A contradictor in two pelvic mesh class actions against Johnson & Johnson has opposed Shine Lawyers recovering $100 million in costs from a $300 million settlement, which a judge has preliminarily found is not fair and reasonable to group members.
A judge has savaged Shine Lawyers over its failure to present a signed settlement agreement to the court a month after Johnson & Johnson Medical and unit Ethicon agreed to pay $300 million to settle two pelvic mesh class actions, ordering the firm to explain on the record what steps have been taken to finalise the settlement.
Johnson & Johnson Medical and unit Ethicon have agreed to pay $300 million to settle two class actions brought by Shine Lawyers on behalf of Australian women implanted with pelvic mesh and tape devices.